In fact, recent findings found that reduced ABCA1 expression in the macrophages, by proprotein convertase subtilisin/kexin type 9 (PCSK9), could accelerates atherosclerosis, thereby inhibiting RCT [35, 36]. Here, PCSK9 is linked to atherosclerosis.